Optimal Response‐Adaptive Designs for Continuous Responses in Phase III Trials (Q5122989): Difference between revisions
From MaRDI portal
Created claim: MaRDI profile type (P1460): MaRDI publication profile (Q5976449), #quickstatements; #temporary_batch_1710496893715 |
Normalize DOI. |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Property / DOI | |||
| Property / DOI: 10.1002/bimj.200610358 / rank | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1002/bimj.200610358 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W1996036118 / rank | |||
Normal rank | |||
| Property / Wikidata QID | |||
| Property / Wikidata QID: Q80849539 / rank | |||
Normal rank | |||
| Property / DOI | |||
| Property / DOI: 10.1002/BIMJ.200610358 / rank | |||
Normal rank | |||
Latest revision as of 16:01, 30 December 2024
scientific article; zbMATH DE number 7251705
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimal Response‐Adaptive Designs for Continuous Responses in Phase III Trials |
scientific article; zbMATH DE number 7251705 |
Statements
Optimal Response‐Adaptive Designs for Continuous Responses in Phase III Trials (English)
0 references
25 September 2020
0 references
constraints
0 references
ethical allocation
0 references
minimization
0 references
truncated normal distribution
0 references
two parameter exponential family
0 references
